Cargando…
Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer
BACKGROUND: In the U.S., lung cancer accounts for 14% of cancer diagnoses and 28% of cancer deaths annually. Since no cure exists for advanced lung cancer, the main treatment goal is to prolong survival. Chemotherapy regimens produce side effects with different profiles. Coupling this with individua...
Autores principales: | Islam, K. M., Anggondowati, T., Deviany, P. E., Ryan, J. E., Fetrick, A., Bagenda, D., Copur, M. S., Tolentino, A., Vaziri, I., McKean, H. A., Dunder, S., Gray, J. E., Huang, C., Ganti, A. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712837/ https://www.ncbi.nlm.nih.gov/pubmed/31455252 http://dx.doi.org/10.1186/s12885-019-6054-x |
Ejemplares similares
-
Impact of time-to-treatment on overall survival of non-small cell lung cancer patients—an analysis of the national cancer database
por: Anggondowati, Trisari, et al.
Publicado: (2020) -
Motion fluency effects on object preference is limited to learned context
por: Flavell, Jonathan Charles, et al.
Publicado: (2020) -
Chemotherapy options in castration-resistant prostate cancer
por: Teply, Benjamin A., et al.
Publicado: (2016) -
Metformin: A Possible Option in Cancer Chemotherapy
por: Ugwueze, Chidiebere V., et al.
Publicado: (2020) -
Chemotherapy-Induced Myopathy: The Dark Side of the Cachexia Sphere
por: Campelj, Dean G., et al.
Publicado: (2021)